Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

v3.22.1
Subsequent Events
6 Months Ended
Feb. 28, 2022
Subsequent Events  
21. Subsequent Events

21.

Subsequent Events

 

On March 8, 2022 Lexaria granted 36,700 stock options bearing an exercise price of $3.39 for a period of five years ending March 8, 2027. The Options were issued pursuant to the Company’s registered Incentive Equity Plan and any common shares issued upon the exercise of the Options will be unrestricted securities.